BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30692987)

  • 1. ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation.
    Barzaghi F; Minniti F; Mauro M; Bortoli M; Balter R; Bonetti E; Zaccaron A; Vitale V; Omrani M; Zoccolillo M; Brigida I; Cicalese MP; Degano M; Hershfield MS; Aiuti A; Bondarenko AV; Chinello M; Cesaro S
    Front Immunol; 2018; 9():2767. PubMed ID: 30692987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis.
    Alsultan A; Basher E; Alqanatish J; Mohammed R; Alfadhel M
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29271561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.
    Hashem H; Kumar AR; Müller I; Babor F; Bredius R; Dalal J; Hsu AP; Holland SM; Hickstein DD; Jolles S; Krance R; Sasa G; Taskinen M; Koskenvuo M; Saarela J; van Montfrans J; Wilson K; Bosch B; Moens L; Hershfield M; Meyts I;
    Blood; 2017 Dec; 130(24):2682-2688. PubMed ID: 28974505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency.
    Barzaghi F; Cicalese MP; Zoccolillo M; Brigida I; Barcella M; Merelli I; Sartirana C; Zanussi M; Calbi V; Bernardo ME; Tucci F; Migliavacca M; Giglio F; Doglio M; Canarutto D; Ferrua F; Consiglieri G; Prunotto G; Saettini F; Bonanomi S; Rovere-Querini P; Di Colo G; Jofra T; Fousteri G; Penco F; Gattorno M; Hershfield MS; Bongiovanni L; Ponzoni M; Marktel S; Milani R; Peccatori J; Ciceri F; Mortellaro A; Aiuti A
    Front Immunol; 2022; 13():910021. PubMed ID: 36248833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.
    Nanthapisal S; Murphy C; Omoyinmi E; Hong Y; Standing A; Berg S; Ekelund M; Jolles S; Harper L; Youngstein T; Gilmour K; Klein NJ; Eleftheriou D; Brogan PA
    Arthritis Rheumatol; 2016 Sep; 68(9):2314-22. PubMed ID: 27059682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
    Dell'Orso G; Grossi A; Penco F; Caorsi R; Palmisani E; Terranova P; Schena F; Lupia M; Ricci E; Montalto S; Pierri F; Ceccherini I; Fioredda F; Dufour C; Gattorno M; Miano M
    Front Immunol; 2021; 12():754029. PubMed ID: 34721429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
    Meyts I; Aksentijevich I
    J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monogenic polyarteritis: the lesson of ADA2 deficiency.
    Caorsi R; Penco F; Schena F; Gattorno M
    Pediatr Rheumatol Online J; 2016 Sep; 14(1):51. PubMed ID: 27609179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
    Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
    J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-onset stroke and vasculopathy associated with mutations in ADA2.
    Zhou Q; Yang D; Ombrello AK; Zavialov AV; Toro C; Zavialov AV; Stone DL; Chae JJ; Rosenzweig SD; Bishop K; Barron KS; Kuehn HS; Hoffmann P; Negro A; Tsai WL; Cowen EW; Pei W; Milner JD; Silvin C; Heller T; Chin DT; Patronas NJ; Barber JS; Lee CC; Wood GM; Ling A; Kelly SJ; Kleiner DE; Mullikin JC; Ganson NJ; Kong HH; Hambleton S; Candotti F; Quezado MM; Calvo KR; Alao H; Barham BK; Jones A; Meschia JF; Worrall BB; Kasner SE; Rich SS; Goldbach-Mansky R; Abinun M; Chalom E; Gotte AC; Punaro M; Pascual V; Verbsky JW; Torgerson TR; Singer NG; Gershon TR; Ozen S; Karadag O; Fleisher TA; Remmers EF; Burgess SM; Moir SL; Gadina M; Sood R; Hershfield MS; Boehm M; Kastner DL; Aksentijevich I
    N Engl J Med; 2014 Mar; 370(10):911-20. PubMed ID: 24552284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
    Hashem H; Bucciol G; Ozen S; Unal S; Bozkaya IO; Akarsu N; Taskinen M; Koskenvuo M; Saarela J; Dimitrova D; Hickstein DD; Hsu AP; Holland SM; Krance R; Sasa G; Kumar AR; Müller I; de Sousa MA; Delafontaine S; Moens L; Babor F; Barzaghi F; Cicalese MP; Bredius R; van Montfrans J; Baretta V; Cesaro S; Stepensky P; Benedicte N; Moshous D; Le Guenno G; Boutboul D; Dalal J; Brooks JP; Dokmeci E; Dara J; Lucas CL; Hambleton S; Wilson K; Jolles S; Koc Y; Güngör T; Schnider C; Candotti F; Steinmann S; Schulz A; Chambers C; Hershfield M; Ombrello A; Kanakry JA; Meyts I
    J Clin Immunol; 2021 Oct; 41(7):1633-1647. PubMed ID: 34324127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort.
    Barron KS; Aksentijevich I; Deuitch NT; Stone DL; Hoffmann P; Videgar-Laird R; Soldatos A; Bergerson J; Toro C; Cudrici C; Nehrebecky M; Romeo T; Jones A; Boehm M; Kanakry JA; Dimitrova D; Calvo KR; Alao H; Kapuria D; Ben-Yakov G; Pichard DC; Hathaway L; Brofferio A; McRae E; Moura NS; Schnappauf O; Rosenzweig S; Heller T; Cowen EW; Kastner DL; Ombrello AK
    Front Immunol; 2021; 12():811473. PubMed ID: 35095905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.
    Van Montfrans JM; Hartman EA; Braun KP; Hennekam EA; Hak EA; Nederkoorn PJ; Westendorp WF; Bredius RG; Kollen WJ; Schölvinck EH; Legger GE; Meyts I; Liston A; Lichtenbelt KD; Giltay JC; Van Haaften G; De Vries Simons GM; Leavis H; Sanders CJ; Bierings MB; Nierkens S; Van Gijn ME
    Rheumatology (Oxford); 2016 May; 55(5):902-10. PubMed ID: 26867732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of ADA2 deficient polyarteritis nodosa.
    Human A; Pagnoux C
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():69-77. PubMed ID: 29624883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Spectrum of Clinical Findings from ALPS to CVID: Several Novel LRBA Defects.
    Cagdas D; Halaçlı SO; Tan Ç; Lo B; Çetinkaya PG; Esenboğa S; Karaatmaca B; Matthews H; Balcı-Hayta B; Arıkoğlu T; Ezgü F; Aladağ E; Saltık-Temizel İN; Demir H; Kuşkonmaz B; Okur V; Gümrük F; Göker H; Çetinkaya D; Boztuğ K; Lenardo M; Sanal Ö; Tezcan İ
    J Clin Immunol; 2019 Oct; 39(7):726-738. PubMed ID: 31432443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China.
    Wang W; Zhang T; Zheng W; Zhong L; Wang L; Li J; Liu Q; Dong Y; Song H
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):44. PubMed ID: 33757531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel frameshift variant in the ADA2 gene of a patient with a neurological phenotype: a case report.
    Lucane Z; Davidsone Z; Micule I; Auzenbaha M; Kurjane N
    Pediatr Rheumatol Online J; 2022 Dec; 20(1):118. PubMed ID: 36528591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2.
    Hashem H; Egler R; Dalal J
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e293-e296. PubMed ID: 28230570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine Deaminase Two and Immunoglobulin M Accurately Differentiate Adult Sneddon's Syndrome of Unknown Cause.
    Santo GC; Baldeiras I; Guerreiro R; Ribeiro JA; Cunha R; Youngstein T; Nanthapisal S; Leitão J; Fernandes C; Caramelo F; Almeida MDR; Brás J; Santana I;
    Cerebrovasc Dis; 2018; 46(5-6):257-264. PubMed ID: 30645994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation.
    Skrabl-Baumgartner A; Plecko B; Schmidt WM; König N; Hershfield M; Gruber-Sedlmayr U; Lee-Kirsch MA
    Pediatr Rheumatol Online J; 2017 Aug; 15(1):67. PubMed ID: 28830446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.